ProRhythm, Inc. Report issue

For profit Phase 3
Founded: Ronkonkoma NY United States (1997)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2006
NCT00392106
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5